征求意见稿-话题@MedSci

#征求意见稿#

53篇内容 | 2063人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2009773, encodeId=4fe52009e73ef, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=国家卫健委发布研究者发起临床研究（IIT）管理办法（征求意见稿）, objectType=article, longId=205120, objectId=d0462051201f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0462051201f, replyNumber=0, likeNumber=71, createdTime=2021-04-14, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0462051201f, moduleTitle=国家卫健委发布研究者发起临床研究（IIT）管理办法（征求意见稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0462051201f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009765, encodeId=f4362009e658c, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=刚刚，国家医保局发布《2020年国家医保药品目录调整工作方案（征求意见稿）》, objectType=article, longId=198689, objectId=88781986891f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88781986891f, replyNumber=0, likeNumber=67, createdTime=2021-02-05, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88781986891f, moduleTitle=刚刚，国家医保局发布《2020年国家医保药品目录调整工作方案（征求意见稿）》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88781986891f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009760, encodeId=47082009e60e5, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=中医禁食疗法专家共识（征求意见稿）, objectType=article, longId=186659, objectId=93181866596c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93181866596c, replyNumber=0, likeNumber=33, createdTime=2020-05-22, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93181866596c, moduleTitle=中医禁食疗法专家共识（征求意见稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93181866596c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009768, encodeId=e76c2009e6829, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=CDE发布《基因治疗产品药学研究与评价技术指导原则（征求意见稿）》, objectType=article, longId=200722, objectId=ba17200e22cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba17200e22cb, replyNumber=0, likeNumber=78, createdTime=2021-03-20, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba17200e22cb, moduleTitle=CDE发布《基因治疗产品药学研究与评价技术指导原则（征求意见稿）》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba17200e22cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009764, encodeId=ef622009e641d, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=产生真实世界证据的真实世界数据指导原则征求意见稿来啦！, objectType=article, longId=198664, objectId=293c198664f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=293c198664f0, replyNumber=0, likeNumber=52, createdTime=2021-03-23, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=293c198664f0, moduleTitle=产生真实世界证据的真实世界数据指导原则征求意见稿来啦！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=293c198664f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009755, encodeId=acaf2009e5561, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示, objectType=article, longId=180747, objectId=9a2a180e47c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a2a180e47c8, replyNumber=0, likeNumber=84, createdTime=2020-03-28, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a2a180e47c8, moduleTitle=真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a2a180e47c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009757, encodeId=c82e2009e57ed, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=CDE发布特殊注射剂质量和疗效一致性评价技术要求（征求意见稿）, objectType=article, longId=182524, objectId=c111182524c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c111182524c9, replyNumber=0, likeNumber=93, createdTime=2020-03-09, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c111182524c9, moduleTitle=CDE发布特殊注射剂质量和疗效一致性评价技术要求（征求意见稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c111182524c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009762, encodeId=7d122009e6288, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=NMPA发布疫情期间药物临床试验管理指导原则征求意见稿, objectType=article, longId=193558, objectId=04d019355837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04d019355837, replyNumber=0, likeNumber=77, createdTime=2020-08-01, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04d019355837, moduleTitle=NMPA发布疫情期间药物临床试验管理指导原则征求意见稿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04d019355837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009763, encodeId=d1c72009e63d8, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, objectType=article, longId=194212, objectId=13c2194212aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c2194212aa, replyNumber=0, likeNumber=78, createdTime=2021-03-23, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c2194212aa, moduleTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c2194212aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009754, encodeId=16772009e5485, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=CDE公开征求《晚期非小细胞肺癌临床试验终点技术指导原则（征求意见稿）》意见, objectType=article, longId=172188, objectId=5ba91e218836, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ba91e218836, replyNumber=0, likeNumber=62, createdTime=2020-01-20, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ba91e218836, moduleTitle=CDE公开征求《晚期非小细胞肺癌临床试验终点技术指导原则（征求意见稿）》意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ba91e218836)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009761, encodeId=d7522009e61b4, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=关于公开征求《利妥昔单抗注射液生物类似药临床试验指导原则（征求意见稿）》意见的通知, objectType=article, longId=190911, objectId=623b190911ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=623b190911ab, replyNumber=0, likeNumber=75, createdTime=2020-11-09, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=623b190911ab, moduleTitle=关于公开征求《利妥昔单抗注射液生物类似药临床试验指导原则（征求意见稿）》意见的通知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=623b190911ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009758, encodeId=e1f72009e581e, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=《健康保险管理办法（征求意见稿）》下发规范健康保险经营行为, objectType=article, longId=182854, objectId=4cc218285454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cc218285454, replyNumber=0, likeNumber=78, createdTime=2020-02-17, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cc218285454, moduleTitle=《健康保险管理办法（征求意见稿）》下发规范健康保险经营行为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cc218285454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009759, encodeId=10d52009e596c, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=食品药品审核查验中心公开征求《GMP附录-细胞治疗产品》（征求意见稿）, objectType=article, longId=183829, objectId=6ee218382984, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ee218382984, replyNumber=0, likeNumber=62, createdTime=2020-01-02, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ee218382984, moduleTitle=食品药品审核查验中心公开征求《GMP附录-细胞治疗产品》（征求意见稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ee218382984)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009751, encodeId=cb322009e5187, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=重磅！国家卫健委办公厅发布《体细胞治疗临床研究和转化应用管理办法（试行）（征求意见稿）》，有效果备案后可收费, objectType=article, longId=163347, objectId=e0a316334ef3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0a316334ef3, replyNumber=0, likeNumber=73, createdTime=2019-07-07, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0a316334ef3, moduleTitle=重磅！国家卫健委办公厅发布《体细胞治疗临床研究和转化应用管理办法（试行）（征求意见稿）》，有效果备案后可收费, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0a316334ef3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009753, encodeId=91022009e533d, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=真实世界证据支持药物研发的基本考虑（征求意见稿）, objectType=article, longId=167166, objectId=13bf16e16607, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13bf16e16607, replyNumber=0, likeNumber=75, createdTime=2019-09-17, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13bf16e16607, moduleTitle=真实世界证据支持药物研发的基本考虑（征求意见稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13bf16e16607)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009756, encodeId=13432009e56e2, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=31条修改，《药品注册管理办法》再次发布征求意见稿, objectType=article, longId=181537, objectId=90e518153e5e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90e518153e5e, replyNumber=0, likeNumber=73, createdTime=2020-09-10, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90e518153e5e, moduleTitle=31条修改，《药品注册管理办法》再次发布征求意见稿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90e518153e5e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009749, encodeId=09312009e49f5, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=保证疫苗安全《疫苗管理法（征求意见稿）》公开征求意见, objectType=article, longId=153347, objectId=1e9b15334e9d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e9b15334e9d, replyNumber=0, likeNumber=70, createdTime=2018-11-25, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e9b15334e9d, moduleTitle=保证疫苗安全《疫苗管理法（征求意见稿）》公开征求意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e9b15334e9d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009752, encodeId=de432009e52e4, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=国家药监局公开征求《关于调整药械组合产品属性界定有关事项的通告（征求意见稿）》意见, objectType=article, longId=164564, objectId=47e91645646d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e91645646d, replyNumber=0, likeNumber=62, createdTime=2019-05-04, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e91645646d, moduleTitle=国家药监局公开征求《关于调整药械组合产品属性界定有关事项的通告（征求意见稿）》意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47e91645646d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009747, encodeId=30d82009e476a, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=NMPA重磅：国家药品监督管理局办公室公开征求关于个例药品不良反应收集和报告指导原则（征求意见稿）意见, objectType=article, longId=148452, objectId=1020148452a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1020148452a7, replyNumber=0, likeNumber=69, createdTime=2018-10-28, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1020148452a7, moduleTitle=NMPA重磅：国家药品监督管理局办公室公开征求关于个例药品不良反应收集和报告指导原则（征求意见稿）意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1020148452a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2009746, encodeId=0bfa2009e464c, content=<a href='/topic/show?id=8d6750352ef' target=_blank style='color:#2F92EE;'>#征求意见稿#</a>, objectTitle=综合防控儿童青少年近视实施方案（征求意见稿）, objectType=article, longId=147270, objectId=9b3914e270f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b3914e270f0, replyNumber=0, likeNumber=58, createdTime=2018-10-21, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3914e270f0, moduleTitle=综合防控儿童青少年近视实施方案（征求意见稿）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b3914e270f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

征求意见稿

2020-05-29

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

国家卫健委发布研究者发起临床研究（IIT）管理办法（征求意见稿）

2021-04-14

柳叶一刀 (审核中...)

前往app查看评论内容

#征求意见稿#

刚刚，国家医保局发布《2020年国家医保药品目录调整工作方案（征求意见稿）》

2021-02-05

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

中医禁食疗法专家共识（征求意见稿）

2020-05-22

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

CDE发布《基因治疗产品药学研究与评价技术指导原则（征求意见稿）》

2021-03-20

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

产生真实世界证据的真实世界数据指导原则征求意见稿来啦！

2021-03-23

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

真实世界证据支持药物研发？ ——读真实世界证据支持药物研发征求意见稿的启示

2020-03-28

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

CDE发布特殊注射剂质量和疗效一致性评价技术要求（征求意见稿）

2020-03-09

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

NMPA发布疫情期间药物临床试验管理指导原则征求意见稿

2020-08-01

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知

2021-03-23

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

CDE公开征求《晚期非小细胞肺癌临床试验终点技术指导原则（征求意见稿）》意见

2020-01-20

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

关于公开征求《利妥昔单抗注射液生物类似药临床试验指导原则（征求意见稿）》意见的通知

2020-11-09

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

《健康保险管理办法（征求意见稿）》下发规范健康保险经营行为

2020-02-17

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

食品药品审核查验中心公开征求《GMP附录-细胞治疗产品》（征求意见稿）

2020-01-02

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

重磅！国家卫健委办公厅发布《体细胞治疗临床研究和转化应用管理办法（试行）（征求意见稿）》，有效果备案后可收费

2019-07-07

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

真实世界证据支持药物研发的基本考虑（征求意见稿）

2019-09-17

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

31条修改，《药品注册管理办法》再次发布征求意见稿

2020-09-10

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

保证疫苗安全《疫苗管理法（征求意见稿）》公开征求意见

2018-11-25

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

国家药监局公开征求《关于调整药械组合产品属性界定有关事项的通告（征求意见稿）》意见

2019-05-04

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

NMPA重磅：国家药品监督管理局办公室公开征求关于个例药品不良反应收集和报告指导原则（征求意见稿）意见

2018-10-28

smlt2008 (审核中...)

前往app查看评论内容

#征求意见稿#

综合防控儿童青少年近视实施方案（征求意见稿）

2018-10-21

科室
- - 订阅+
  - 更多科室
工具
服务